Wird geladen...

Glucose‐lowering agents for treating pre‐existing and new‐onset diabetes in kidney transplant recipients

BACKGROUND: Kidney transplantation is the preferred form of kidney replacement therapy for patients with end‐stage kidney disease (ESKD) and is often complicated by worsening or new‐onset diabetes. Management of hyperglycaemia is important to reduce post‐transplant and diabetes‐related complications...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cochrane Database Syst Rev
Hauptverfasser: Lo, Clement, Jun, Min, Badve, Sunil V, Pilmore, Helen, White, Sarah L, Hawley, Carmel, Cass, Alan, Perkovic, Vlado, Zoungas, Sophia
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley & Sons, Ltd 2017
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464265/
https://ncbi.nlm.nih.gov/pubmed/28238223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009966.pub2
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!